Literature DB >> 2079081

Early-onset myasthenia gravis: clinical characteristics and response to therapy.

A P Batocchi1, A Evoli, M T Palmisani, M Lo Monaco, M Bartoccioni, P Tonali.   

Abstract

We studied 59 children with myasthenia gravis (MG). Disease onset was pre-pubertal in 26 patients and post-pubertal in 33. The male to female ratio was 0.62 in the early- and 0.17 in the late-onset groups. The frequency of ocular MG was higher in patients with prepubertal onset. Patients with generalized MG generally showed a good response to thymectomy and corticosteroid therapy proved effective with no major side-effects. In our experience early-onset MG has the same course as in adult life. We recommend thymectomy for generalized disease in childhood, except in very young children on account of possible long-term effects on immunological development. Immunosuppressive therapy should be considered in severely affected patients who do not respond adequately to other therapies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079081     DOI: 10.1007/BF01959485

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  EFFECT OF THYMECTOMY ON SKIN-HOMOGRAFT SURVIVAL IN CHILDREN.

Authors:  R M ZOLLINGER; M C LINDEM; R M FILLER; J M CORSON; R E WILSON
Journal:  N Engl J Med       Date:  1964-04-02       Impact factor: 91.245

2.  STUDIES IN MYASTHENIA GRAVIS. IMMUNOLOGIC RESPONSE IN THYMECTOMIZED AND NONTHYMECTOMIZED PATIENTS.

Authors:  P KORNFELD; S SIEGAL; L B WEINER; K E OSSERMAN
Journal:  Ann Intern Med       Date:  1965-09       Impact factor: 25.391

3.  T-cell development during ageing in congenitally athymic (nude) rats.

Authors:  L M Vaessen; R Broekhuizen; J Rozing; J G Vos; H J Schuurman
Journal:  Scand J Immunol       Date:  1986-08       Impact factor: 3.487

4.  Synergistic immunosuppressive action of antithymocyte antisera and thymectomy in the human.

Authors:  B Pirofsky; R R Reid; J C Ramirez-Mateos; E J Bardana; A August
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

5.  Letter: Rosette tests following thymectomy.

Authors:  G P Sandilands; K Gray; A Cooney; J R Anderson; J A Simpson; P O Behan
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

6.  Thymectomy for myasthenia gravis in children.

Authors:  S Youssef
Journal:  J Pediatr Surg       Date:  1983-10       Impact factor: 2.545

7.  Early-onset myasthenia gravis.

Authors:  E S Roach; G Buono; W T McLean; R G Weaver
Journal:  J Pediatr       Date:  1986-02       Impact factor: 4.406

8.  Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.

Authors:  E Bartoccioni; F Scuderi; C Scoppetta; A Evoli; P Tonali; L Guidi; C Bartoloni; T Terranova
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

9.  Primary malignant thymoma in a 6-year-old boy.

Authors:  K Shibata; Y Koga; T Onitsuka; S Karashima; S Sawa; T Murayama; M Kohno
Journal:  Jpn J Surg       Date:  1986-11

10.  An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis.

Authors:  J Lindstrom
Journal:  Clin Immunol Immunopathol       Date:  1977-01
View more
  5 in total

1.  Immunoadsorption plasmapheresis for severe generalised myasthenia gravis.

Authors:  M Ichikawa; C S Koh; Y Hata; M Tohyama; T Tsuno; A Komiyama
Journal:  Arch Dis Child       Date:  1993-08       Impact factor: 3.791

2.  Neuromuscular junctional disorders.

Authors:  A S Girija; V V Ashraf
Journal:  Indian J Pediatr       Date:  2008-08-21       Impact factor: 1.967

3.  Anaesthetic considerations in paediatric myasthenia gravis.

Authors:  Oliver William Masters; Oliver N Bagshaw
Journal:  Autoimmune Dis       Date:  2011-09-25

4.  Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.

Authors:  T H Popperud; M K Viken; E Kerty; B A Lie
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

5.  Thoracoscopic thymectomy for juvenile myasthenia gravis.

Authors:  Aimee G Kim; Sydney A Upah; John F Brandsema; Sabrina W Yum; Thane A Blinman
Journal:  Pediatr Surg Int       Date:  2019-02-07       Impact factor: 1.827

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.